Ghost Tree Capital, LLC Uni Qure N.V. Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$5.63 - $8.27 $281,500 - $413,500	-50,000 Reduced 23.26%	165,000 $1.12 Million
Q2 2023 Aug 14, 2023	SELL	$11.12 - $22.2 $1.78 Million - $3.55 Million	-160,000 Reduced 42.67%	215,000 $2.46 Million
Q1 2023 May 15, 2023	BUY	$18.7 - $23.07 $7.01 Million - $8.65 Million	375,000 New	375,000 $7.55 Million
Q3 2019 Nov 14, 2019	SELL	$39.36 - $76.8 $1.38 Million - $2.69 Million	-35,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $1.85 Million - $2.88 Million	35,000 New	35,000 $2.74 Million

156

40.5M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $754M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.